Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer

NCT03103321 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2025-01-27

Study results available
· View outcomes & findings →

Summary

This randomized phase III trial studies how well decision aids work in improving knowledge in patients with newly diagnosed prostate cancer. Decision aids may improve patients' knowledge of their condition and options for treatment, and may also help when talking with their doctor.

Conditions

  • Stage II Prostate Cancer
  • Stage IIA Prostate Cancer
  • Stage IIB Prostate Cancer
  • Stage III Prostate Cancer
  • Stage I Prostate Cancer
  • PSA Level Five to Ten
  • PSA Level Less Than Five
  • PSA Level Ten to Fifty

Interventions

OTHER

Internet-Based Intervention

Receive "Knowing your Options" decision aid

OTHER

Internet-Based Intervention

Receive "Prostate Choice" decision aid

OTHER

Best Practice

Undergo usual care

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Survey Administration

Ancillary studies

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-02
Primary Completion
2019-12-05
Completion
2020-11-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03103321 on ClinicalTrials.gov